The lack of estrogen receptor (ER) in MDA-MB-231 has made it unresponsive to antiestrogen therapy, including the commonly used selective estrogen receptor modulator tamoxifen in BC prevention and treatment (Radmacher and Simon, 2000). This evidence concerns the gene ESR1 and breast cancer.